Smpd2 Publications

Smpd2 Model Page

Filter publications by application: All
Filter publications by model type: All

Author(s)

(Date)

Paper Title

Citation

Model Type

Applications

Full Text

Zumbansen M, et al.
Mouse over for full list
Zumbansen M, Stoffel W
(2002) Neutral sphingomyelinase 1 deficiency in the mouse causes no lipid storage disease. Mol. Cell. Biol. 22(11):3633-8
Mizutani Y, et al.
Mouse over for full list
Mizutani Y, Tamiya-Koizumi K, Irie F, Hirabayashi Y, Miwa M, Yoshida S
(2000) Cloning and expression of rat neutral sphingomyelinase: enzymological characterization and identification of essential histidine residues. Biochim. Biophys. Acta 1485(2-3):236-46
Adam-Klages S, et al.
Mouse over for full list
Adam-Klages S, Schwandner R, Adam D, Kreder D, Bernardo K, Krönke M
(1998) Distinct adapter proteins mediate acid versus neutral sphingomyelinase activation through the p55 receptor for tumor necrosis factor. J. Leukoc. Biol. 63(6):678-82
Levade T, et al.
Mouse over for full list
Levade T, Jaffrézou JP
(1999) Signalling sphingomyelinases: which, where, how and why? Biochim. Biophys. Acta 1438(1):1-17
Tomiuk S, et al.
Mouse over for full list
Tomiuk S, Hofmann K, Nix M, Zumbansen M, Stoffel W
(1998) Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling? Proc. Natl. Acad. Sci. U.S.A. 95(7):3638-43
Stein JM
Mouse over for full list
Stein JM
(1975) The effect of adrenaline and of alpha- and beta-adrenergic blocking agents on ATP concentration and on incorporation of 32Pi into ATP in rat fat cells. Biochem. Pharmacol. 24(18):1659-62